MS1 TOWARD ESTABLISHMENT OF ROUTINE MOLECULAR DIAGNOSTICS FOR ADULT GLIOMAS UNDER THE NATIONAL HEALTH INSURANCE

por Ichimura, Koichi
Publicado 2019

Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions

por Takami, Hirokazu, Ichimura, Koichi
Publicado 2022

Protein Phosphatases—A Touchy Enemy in the Battle Against Glioblastomas: A Review

por Tomiyama, Arata, Kobayashi, Tatsuya, Mori, Kentaro, Ichimura, Koichi
Publicado 2019

ML-12 MECHANISMS OF CELL DEATH INHIBITION THROUGH CHANGE IN SUBCELLULAR LOCALIZATION OF PIM-1 BY PIM1 GENE MUTATION RECURRENTLY FOUND IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

por Sasaki, Nobuyoshi, Ichimura, Koichi, Nagane, Motoo, Tomiyama, Arata
Publicado 2019

ET-02 EFFICACY OF THE SALVAGE THERAPY VIA LOMUSTINE AND NIMUSTINE FOR RECURRENT GLIOBLASTOMA WITH TEMOZOLOMIDE RESISTANCE

por Yamamuro, Shun, Ichimura, Koichi, Takahashi, Masamichi, Tomiyama, Arata
Publicado 2019

GCT-19. MODELING GERM CELL TUMORS WITH KIT MUTANT hiPSCs

por Kuzuoka, Sakura, Kojima, Yoji, Ichimura, Koichi, Saitou, Mitinori
Publicado 2020

GCT-22. PROTEIN DEUBIQUITINATION PATHWAY IS A NOVEL THERAPEUTIC TARGET AGAINST MALIGNANT NON-GERMINOMATOUS CNS GERM CELL TUMORS

por Tomiyama, Arata, Uchida, Eita, Wada, Kojiro, Ichimura, Koichi
Publicado 2020

Still divergent but on the way to convergence: clinical practice of CNS germ cell tumors in Europe and North America from the perspectives of the East

por Takami, Hirokazu, Nakamura, Hideo, Ichimura, Koichi, Nishikawa, Ryo
Publicado 2022

EPEN-34. THE CRISPR-Cas9 SYSTEM-MEDIATED ENDOGENOUS GENE REARRANGEMENT INDUCED C11orf95-RELA FUSION IN VITRO AND IN VIVO THAT LED TO THE DEVELOPMENT OF EPENDYMOMA-LIKE TUMOR

por Takadera, Mutsumi, Ozawa, Tatsuya, Satomi, Kaishi, Yamamoto, Tetsuya, Ichimura, Koichi
Publicado 2020

Histone deacetylase inhibition enhances the therapeutic effects of methotrexate on primary central nervous system lymphoma

por Fujimoto, Kenji, Shinojima, Naoki, Hayashi, Mitsuhiro, Nakano, Tomoyuki, Ichimura, Koichi, Mukasa, Akitake
Publicado 2020

EPEN-41. C11orf95-RELA FUSION REGULATES ABERRANT GENE EXPRESSION THROUGH THE UNIQUE GENOMIC BINDING SITES FOR EPENDYMOMA FORMATION

por Ozawa, Tatsuya, Kaneko, Syuzo, Takadera, Mutsumi, Holland, Eric, Hamamoto, Ryuji, Ichimura, Koichi
Publicado 2020

GCT-46. MULTI-KINASE INHIBITORS AS NOVEL THERAPEUTIC AGENTS AGAINST INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS

por Uchida, Eita, Ozawa, Tatsuya, Takahashi, Masamichi, Nishikawa, Ryo, Ichimura, Koichi, Tomiyama, Arata
Publicado 2020

GCT-19. Toward understanding of the pathogenesis of central nervous system germ cell tumors

por Ichimura, Koichi, Takami, Hirokazu, Satomi, Kaishi, Matsushita, Yuko, Terashima, Keita, Nishikawa, Ryo
Publicado 2022

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years

por Ohno, Makoto, Miyakita, Yasuji, Takahashi, Masamichi, Igaki, Hiroshi, Matsushita, Yuko, Ichimura, Koichi, Narita, Yoshitaka
Publicado 2019

HGG-02. ADOLESCENT AND YOUNG ADULT (AYA) GLIOMA WITH BRAF V600E-MUTANTATION

por Kimura, Yui, Ishi, Yukitomo, Watanabe, Yuko, Nakano, Yoshiko, Yamaguchi, Shigeru, Narita, Yoshitaka, Ichimura, Koichi
Publicado 2020

Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma

por McCabe, Martin G., Bäcklund, L. Magnus, Leong, Hui Sun, Ichimura, Koichi, Collins, V. Peter
Publicado 2011

MPC-02 REVIEW OF MEDULLOBLASTOMA FOR THE ASSESSMENT OF CONSENSUS IN PATHOLOGICAL DIAGNOSIS USING JPMNG CASES

por Sasaki, Atsushi, Hirato, Jyunko, Inoue, Takeshi, Kanemura, Yonehiro, Kodama, Yoshinori, Ichimura, Koichi, Sakamoto, Hiroaki, Nishikawa, Ryo
Publicado 2019

ET-09 ACQUIRED MALIGNANT BEHAVIORS OF NPE6-PDT-SURVIVED GLIOBLASTOMA CELLS ARE SUPPRESSED BY USING MEK1/2 INHIBITOR TRAMETINIB

por Kobayashi, Tatsuya, Muragaki, Yoshihiro, Takahashi, Masamichi, Wada, Kojiro, Mori, Kentaro, Kawamata, Takakazu, Ichimura, Koichi, Tomiyama, Arata
Publicado 2019

ACT-01 THE SECOND GENERATION ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITOR CERITINIB EFFECTIVELY INDUCES CELL DEATH IN HUMAN GLIOBLASTOMA CELLS

por Kawauchi, Daisuke, Takahashi, Masamichi, Yamamuro, Shun, Kobayashi, Tatsuya, Uchida, Eita, Iwadate, Yasuo, Ichimura, Koichi, Tomiyama, Arata
Publicado 2019

ET-05 Alectinib and ceritinib, the second-generation ALK inhibitors, effectively induce glioblastoma cell death

por Kawauchi, Daisuke, Takahashi, Masamichi, Yamamuro, Shun, Kobayashi, Tatsuya, Uchida, Eita, Iwadate, Yasuo, Ichimura, Koichi, Tomiyama, Arata
Publicado 2020